Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
Commonwealth Biotechnologies reports financial results through September
December 13th, 2006
Commonwealth Biotechnologies, Inc. (CBTE), a solutions provider to the global biotechnology industry, government agencies, pharmaceutical companies, and academic institutions, released its financial results for the third quarter ended September 30, 2006 (the 2006 quarter). The company's 10-QSB was expected to be released on or about November 14, 2006. The third quarter and year-to-date losses now being reported are attributable to the lack of contract signings earlier in the year and to delayed and canceled contracts experienced throughout the course of the year. Revenues in the 2006 quarter were down compared to the third quarter of 2005 (the 2005...
Source: Vaccine Weekly (2006-12-13)
|
